, /PRNewswire/ -- The global size is estimated to grow by billion from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of over 5.79% during the forecast period.
For more insights on the forecast market size and historic data (2017 - 2021) - Assisted Reproductive Technology (ART) market has witnessed significant growth, particularly in the areas of intratubal insemination and fertility clinics. Single women, including those with minor fertility conditions and those who are divorced, separated, widowed, or not married, have doubled in number since the start of the decade. They face challenges such as financial aid, health insurance, child care, and support from absent parents.
ART includes various techniques like ovarian stimulation, embryo transfer, and fertility drugs. Ethical issues, prematurity, reduced success rates, and socio-ethical concerns are also prevalent in ART. Key procedures include intrauterine insemination, intracervical insemination, and intravaginal insemination.
ART also encompasses gamete and embryo cryopreservation, surrogacy, and fertility medication for men and women. Research report provides comprehensive data on impact of trend, driver and challenges - The Assisted Reproductive Technology (ART) market is segmented by application into various categories, including Intratubal insemination, treatment for minor fertility conditions, same-sex couples, single women, and infertility treatments provided in fertility clinics and hos.
